Data from multiple sources - Curated by Toby Galbraith - Last updated 06 June 2017

Latest news articles

Added 5 days ago Drug news

Mylan N.V. and Biocon Ltd. announced that the FDA Oncologic Drugs Advisory Committee (ODAC) recommended approval of the companies' proposed biosimilar trastuzumab.

Mylan N.V. and Biocon Ltd. announced that the FDA Oncologic Drugs Advisory Committee (ODAC) recommended approval of the companies' proposed...

Added 18 days ago Drug news

FDA approves supplemental application for Vectibix (panitumumab) in wild-type RAS metastatic colorectal cancer- Amgen

The FDA has approved the supplemental Biologics License Application (sBLA) for Vectibix (panitumumab), from Amgen, for patients with wild-type RAS...

Added 19 days ago Drug news

PLENVU (NER 1006) is filed at FDA to provide complete bowel cleansing. Norgine + Salix

Norgine B.V. announced that it has received acceptance from the FDA for the New Drug Application (NDA) for PLENVU (NER...

Search all news articles for Gastroenterology and hepatology
 

 

Learning Zones

An epgonline.org Learning Zone (LZ) is an area of the site dedicated to providing detailed self-directed medical education about a disease, condition or procedure.

Cystic Fibrosis

View disease awareness information, treatment options and European Cystic Fibrosis Society best practice guidelines

Visit Cystic Fibrosis


Fluid Management

Are you up-to-date with the latest evidence of effective procedures for fluid management?

Visit Fluid Management


Transplantation

See information on best practice in solid organ transplantation, and expert discussions on related hot topics.

Visit Transplantation


 

Guidelines

American Association of Clinical Endocrinologists and American College of Endocrinology guidelines for management of dyslipidemia and prevention of atherosclerosis.

The development of these guidelines is mandated by the American Association of Clinical Endocrinologists (AACE) Board of Directors and American College of Endocrinology (ACE) Board of Trustees.

Added 4 months ago

2016 ESC/EAS guidelines for the management of dyslipidaemias

Guidelines summarize and evaluate all available evidence on a particular issue at the time of the writing process, with the aim of assisting health professionals in selecting the best management strategies for an individual patient.

Added 4 months ago

EASL Clinical Practice Guidelines on the management of benign liver tumours

Benign liver tumours are a heterogeneous group of lesions with different cellular origins, as summarized by an international panel of...

Added 1 year ago

Search all guidelines for Gastroenterology and hepatology
 

Journal articles

Rolapitant for the prevention of delayed nausea and vomiting over initial and repeat courses of emetogenic chemotherapy.

Introduction: Chemotherapy-induced nausea and vomiting (CINV) is a debilitating side effect of many cytotoxic chemotherapy regimens. Although sustained antiemetic control across repeated chemotherapy cycles ...

Added 1 month ago

Differential clinical pharmacology of rolapitant in delayed chemotherapy-induced nausea and vomiting (CINV).

Rolapitant is a highly selective neurokinin-1 receptor antagonist, orally administered for a single dose of 180 mg before chemotherapy with granisetron D1, dexamethasone 8 mg BID on day 2-4.

Added 1 month ago

Differential pharmacology and clinical utility of rolapitant in chemotherapy-induced nausea and vomiting.

Chemotherapy-induced nausea and vomiting (CINV) is a debilitating side effect of many cytotoxic chemotherapy regimens. CINV typically manifests during two well-defined time periods (acute and delayed phases).

Added 1 month ago

Search all journal articles for Gastroenterology and hepatology
 

Clinical trials

Sorafenib and Bavituximab Plus SBRT in Unresectable Hepatocellular Carcinoma

This study involves a course of radiation to up to 5 tumors in the participant's liver followed by systemic therapy (Treatment using substances that travel through the bloodstream, reaching and affecting cells all over the body).

Added 3 months ago

Rovalpituzumab Tesirine in Delta-Like Protein 3-Expressing Advanced Solid Tumors

To assess the safety and tolerability of rovalpituzumab tesirine in subjects with specific delta-like protein 3-expressing advanced solid tumors.

Added 2 years ago

Prove of Concept Study, to Evaluate the Efficacy, Safety, and Tolerability of IBEROGAST in the Treatment of Bowel Troubles in Patients With Parkinson's Disease (PHYTOPARK)

The main objective of this study is to evaluate the efficacy of STW5 Iberogast, over a 28-day period, for the...

Added 2 years ago

Search all clinical trials for Gastroenterology and hepatology
 

Blog Posts

Liam Farrell

Bad smells are good

Posted 9 months ago

Delicacy is not a virtue in this job.

Hugh Harvey

Metrics Madness

Posted 1 year ago

You shouldn't judge a book by its cover. That much is true, but it's also common sense not to judge a book by measuring the whiteness of its pages, or the amount of hamsters you can place on it. So why do we measure the fabulous NHS with nonsense metrics?

Yuli Pramana

Choosing Between Endoscopic Sclerotherapy And Endoscopic Ligation For Esophageal Varices

Posted 2 years ago

Endoscopic Sclerotherapy (ES) and Endoscopic Ligation (EL) were accepted in the treatment of esophageal varices bleeding in patients with liver cirrhosis. EL seemed to be superior to ES. If EL was difficult then ES should be performed.

CME

Obesity: clinical review

Accrediting body
MIMS Learning - Monthly Index of Medical Specialities
Credits available
1
Registration required
1
Subscription fee
0

The diagnostic value of hyperammonemia induced by the non-ischemic forearm exercise test

Accrediting body
BMJ Learning - British Medical Learning
Credits available
1
Registration required
1
Subscription fee
90

Idiopathic constipation and nocturnal enuresis in childhood: a guide to management: putting NICE guidelines into practice

Accrediting body
BMJ Learning - British Medical Learning
Credits available
1
Registration required
1
Subscription fee
90
Search all CME for Gastroenterology and hepatology